The epidemiology and management of postmenopausal osteoporosis: a viewpoint from Brazil
Luiz Francisco Baccaro,1 Délio Marques Conde,2 Lúcia Costa-Paiva,1 Aarão Mendes Pinto-Neto11Department of Gynecology, State University of Campinas (UNICAMP), Campinas, São Paulo, Brazil; 2Breast Clinic, Hospital for Maternal and Child Healthcare, Goi&a...
Guardado en:
Autores principales: | Baccaro LF, Conde DM, Costa-Paiva L, Pinto-Neto AM |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5b9595c6a4174e359a09129253dbaf0e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis
por: Paula Rackoff
Publicado: (2009) -
Comparison of OSTA, FRAX and BMI for Predicting Postmenopausal Osteoporosis in a Han Population in Beijing: A Cross Sectional Study
por: Fan Z, et al.
Publicado: (2020) -
LncRNA CASC11 is upregulated in postmenopausal osteoporosis and is correlated with TNF-α
por: Yu H, et al.
Publicado: (2019) -
Increased Osteoblastic Cxcl9 Contributes to the Uncoupled Bone Formation and Resorption in Postmenopausal Osteoporosis
por: Liu Z, et al.
Publicado: (2020) -
Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene
por: Luigi Gennari, et al.
Publicado: (2010)